Targeting CCR4 with mogamulizumab in refractory CD3<sup>-</sup>CD4<sup>+</sup> lymphocytic-variant hypereosinophilic syndrome
oleh: Emmanuel Ledoult, Matthieu Groh, Bertrand Meresse, Romain Dubois, Jacques Trauet, Elise Toussaint, Marie Delbeke, Eric Hachulla, Louis Terriou, Adèle De Masson, Michele Vasseur, Myriam Labalette, David Launay, Jean-Emmanuel Kahn, Guillaume Lefevre
| Format: | Article |
|---|---|
| Diterbitkan: | Ferrata Storti Foundation 2024-02-01 |
Deskripsi
No description available for this item.